Cargando…

Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis

Immune checkpoint inhibitor (ICI)-induced myocarditis is a potentially life-threatening adverse event. We herein report a rare case of sick sinus syndrome (SSS) co-occurring with ICI-associated myocarditis. A 71-year-old woman with lung cancer undergoing pembrolizumab monotherapy was admitted owing...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Tatsuya, Kunimasa, Kei, Ohta-Ogo, Keiko, Ikeda, Yoshihiko, Yasui, Taku, Shioyama, Wataru, Oka, Toru, Honma, Keiichiro, Hatakeyama, Kinta, Kumagai, Toru, Fujita, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381348/
https://www.ncbi.nlm.nih.gov/pubmed/35283377
http://dx.doi.org/10.2169/internalmedicine.8575-21
Descripción
Sumario:Immune checkpoint inhibitor (ICI)-induced myocarditis is a potentially life-threatening adverse event. We herein report a rare case of sick sinus syndrome (SSS) co-occurring with ICI-associated myocarditis. A 71-year-old woman with lung cancer undergoing pembrolizumab monotherapy was admitted owing to a fever, worsening kidney function, and sinus bradycardia. She was diagnosed with multi-organ immune-related adverse events, including myocarditis. Pulse steroid therapy was initiated immediately under the support of a temporary pacemaker, which resulted in the resolution of SSS in a few days. Biopsy specimens of the endomyocardium showed active myocarditis. Thus, we should be aware that SSS can co-occur with ICI-induced myocarditis.